En Es
Categories

Industry News

Philips Partners with Hologic to Provide Solutions for Women's Health

By Medimaging International staff writers
12 Mar 2018

Image: The 3Dimensions mammography system (Photo courtesy of Hologic).Royal Philips (Amsterdam, the Netherlands) has entered into a partnership with Hologic (Marlborough, MA, USA) to offer care professionals integrated solutions comprising diagnostic imaging modalities, advanced informatics and services for screening, diagnosis and treatment of women, worldwide.

Philips is focused on diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care, while Hologic focuses on improving women's health and well-being through early detection and treatment. The collaboration combines Hologic's mammography technologies and Philips' portfolio of ultrasound, MRI, CT, and X-ray systems, advanced informatics and broad range of services, including maintenance, upgrade, training and operational performance management services.

Under the agreement, Philips will be able to offer select products from Hologic's breast health portfolio as part of multi-modality deals for hospitals and health systems. This will include Hologic's 3Dimensions mammography system, which is considered to be the fastest, highest resolution breast tomosynthesis system in the industry, as well as other technologies for breast screening and interventional radiology. The multi-year, non-exclusive global partnership agreement allows for customized regional implementation to best meet the individual needs of each customer.

"No two women are alike, and we are teaming up with care providers and leading industry partners to support the delivery of a tailored, seamless breast care experience for women," said Rob Cascella, CEO Diagnosis & Treatment businesses for Royal Philips. "That is why I am very pleased to announce our new partnership with Hologic for mammography. This partnership allows us to offer a complete set of innovative diagnostic imaging systems, software and services to our customers, including Hologic's market-leading mammography solutions for breast screening and diagnosis of women in need of care."

"Hologic believes in enabling doctors with superior technology that improves women's health through early detection and treatment," said Pete Valenti, Hologic's Division President, Breast and Skeletal Health Solutions. "Our market-leading mammography solutions perfectly complement Philips' portfolio, making Hologic the right industry partner for this first-of-its-kind collaboration. Now, through the partnership, Hologic can join Philips when engaging with customers on projects that were not previously possible for the two companies alone. It's a win for everyone involved, including the customers and patients we serve."



E-mail Print
FaceBook Twitter Google+ Linked in

Philips Healthcare

Operates in Diagnostic Imaging Systems, Patient Care and Clinical Informatics, Customer Services, and Home Healthcare with a strong presence in cardio-pulmonary, oncology and women’s health
More info

More articles about Philips Healthcare

05 Apr 2019
Philips Acquires Direct Radiology Teleradiology Platform
Royal Philips is expanding its radiology solutions portfolio with innovative teleradiology services, aimed at addressing the increasing shortage of radiologists, as well as the pressing need to improve access to precision diagnoses.
Read More
30 Oct 2018
Philips Launches Start-Up AI Collaboration Program
Royal Philips has launched its first global start-up collaboration program involving the company’s innovation hubs in Cambridge, US, Eindhoven, the Netherlands, Bangalore, India and Shanghai, China focused on the application of artificial intelligence (AI) in healthcare. The program focuses on the application of AI-based clinical decision support tools, such as image interpretation, analysis and integration, and workflow tools, such as intelligent treatment plans for radiology, ultrasound and oncology.
Read More
22 Aug 2018
Intel and Philips Partner to Speed Up Imaging Analysis Using AI
Intel Corporation and Royal Philips have tested two healthcare use cases for deep learning inference models: one on X-rays of bones for bone-age-prediction modeling and the other on CT scans of lungs for lung segmentation. In these tests, which were conducted using Intel Xeon Scalable processors and the OpenVINO toolkit, the researchers achieved a speed improvement of 188 times for the bone-age-prediction model and 38 times for the lung-segmentation model over the baseline measurements. These tests show that healthcare organizations can implement artificial intelligence (AI) workloads without expensive hardware investments.
Read More
25 Jun 2018
Philips Acquires Remote Diagnostic Technologies to Expand Therapeutics
Royal Philips has acquired Remote Diagnostic Technologies, which offers advanced solutions for the pre-hospital market providing monitoring, cardiac therapy and data management. RDT’s portfolio of connected emergency care solutions will complement Philips’ Therapeutic Care business and strengthen its leadership position in the resuscitation and emergency care market. RDT’s acquisition will also strengthen Philips’ ability to innovate, drive digital transformation in healthcare, and enter new markets.
Read More
12 Mar 2018
Philips Launches Artificial Intelligence Platform for Healthcare
Royal Philips has launched HealthSuite Insights, including the Insights Marketplace, to support the advancing adoption of analytics and artificial intelligence (AI) in key healthcare domains. HealthSuite Insights, which made its debut at the 2018 HIMSS Conference & Exhibition (HIMSS18), gives data scientists, software developers, clinicians and healthcare providers access to advanced analytic capabilities to curate and analyze healthcare data, and offers them tools and technologies to build, maintain, deploy and scale AI-based solutions. Insights Marketplace will provide the healthcare industry's first ecosystem where curated AI assets from Philips and others are readily available for license.
Read More
21 Nov 2017
Philips and Nuance to Bring AI Directly into Radiology Reporting
Health technology company Royal Philips and Nuance Communications, Inc., a provider of intelligent voice and language solutions, will jointly bring artificial intelligence-based (AI-based) image interpretation and reporting capabilities to radiologists.
Read More
25 Oct 2017
Philips and Huawei Initiate Cloud AI Healthcare Project
Royal Philips and Huawei Technologies Co., Ltd. have signed an MoU for the deployment of a cloud-based healthcare solution. The project targeting China’s smaller urban centers has already completed testing and aims to expand high-quality cloud-driven healthcare to communities that lack advanced healthcare solutions or physicians with specialist skills.
Read More
15 Aug 2017
Philips Sells MR-HIFU Business to Profound Medical
Royal Philips has completed the sale of its Sonalleve MR-HIFU business to Profound Medical Inc.
Read More

Additional news

07 Nov 2019
Global Automated Breast Ultrasound Systems Market to Surpass USD 1.8 Billion by 2025
The global automated breast ultrasound systems (ABUS) market was valued at over USD 0.68 billion in 2018 and is projected to grow at a CAGR 16.1% during the forecast period, 2019-2025 to surpass USD 1.8 billion by 2025, driven by increasing government expenditure and rising awareness about breast cancer. Initiatives such as free check-up camps and symposiums for raising awareness regarding early detection and diagnosis of breast cancer will lead to greater adoption of ABUS in the coming years. However, stringent regulations and guidelines for the approval of ABUS, coupled with the high cost of diagnostic procedure, could hamper the market growth during the forecast period.
Read More
07 Nov 2019
CT System Receives FDA Clearance for AI-Based Image Reconstruction Technology
Canon Medical Systems USA, Inc. (Tustin, CA, USA; www.us.medical.canon) has received 510(k) clearance for its Advanced Intelligent Clear-IQ Engine (AiCE) for the Aquilion Precision, further expanding access to its new deep convolutional neural network (DCNN) image reconstruction technology. The technology, which is now available on Canon’s Aquilion Precision and Aquilion ONE/GENESIS Edition CT systems, uses a deep learning algorithm to differentiate signal from noise so that it can suppress noise while enhancing signal, thus improving CT image reconstruction.
Read More
07 Nov 2019
AI-Powered MRI Image Enhancement Software Receives FDA Clearance
A new image processing software that utilizes proprietary deep learning algorithms to bring the latest imaging enhancement technology to existing scanners has received 510(k) clearance from the US Food and Drug Administration (FDA). The software named SubtleMR uses denoising and resolution enhancement to improve image quality and has been developed by Subtle Medical (Menlo Park, CA, USA; www.subtlemedical.com), a healthcare technology company focused on improving the quality, efficiency, and accessibility of medical imaging.
Read More
06 Nov 2019
UCSF Launches Artificial Intelligence Center to Advance Medical Imaging
The University of California San Francisco {(UCSF) San Francisco, CA, USA; www.ucsf.edu} has announced the launch of a new center to accelerate the application of artificial intelligence (AI) technology to radiology, leveraging advanced computational techniques and industry collaborations to improve patient diagnoses and care. The Center for Intelligent Imaging, or ci2, will develop and apply AI to devise powerful new ways to look inside the body and to evaluate health and disease. The center aims to enable transformation via intelligent radiology, with the goal of again collaborating with the industry to become of the first institutions to bring medical imaging AI to the bedside.
Read More
06 Nov 2019
Global Blood Gas and Electrolyte Analyzers Market to Surpass USD 2.1 Billion by 2025
The global blood gas and electrolyte analyzers market is projected to grow at a CAGR of 6.5% during the forecast period, 2018-2025 to reach a value of over USD 2.1 billion by 2025, driven mainly by the Bench Top segment which is anticipated to bring in healthy gains and add significant momentum to the market growth. The Bench Top segment is projected to grow at a CAGR of over 6.4% during the forecast period.
Read More
06 Nov 2019
AI-Powered Diagnostics Software Guides Cardiologists during Angiography
Researchers are in the initial stages of a pivotal multi-center clinical trial to demonstrate the efficacy of AutocathFFR, a fully automated system that detects stenoses (narrowing) in the coronary arteries surrounding the heart. AutocathFFR provides cardiologists with the relevant physiological parameters that can help them in assessing the severity of their patients' condition and devise the optimal treatment strategy.
Read More
06 Nov 2019
IoT-Enabled Healthcare Equipment Market Projected to Reach USD 69.7 Billion by 2023
The global IoT-enabled healthcare equipment market is projected to grow at the rate of 29.9% annually from USD 18.8 billion in 2018 to USD 69.7 billion in 2023, driven by digitization during the forecast period. Medical devices companies are transforming from device or consumable providers to disease and care management organizations. Digitization in acute or chronic care is greatly aided by IoT-enabled medical devices, such as subcutaneous drug delivery units, continuous glucose monitors and vitals monitoring equipment. The emergence of digital enterprises such as Google and Apple in the consumer health space has led to development of new opportunities and innovations for medical devices companies.
Read More
05 Nov 2019
AI-Driven Software Uses CT Scans to Determine Extent of Brain Injury in Stroke Patients
A new study has shown that an artificial intelligence (AI) driven software can reliably tell doctors how much brain is injured in stroke patients using universally available CT scans, without the need for more complex advanced imaging.
Read More
05 Nov 2019
AI in Medicine Projected to Reach USD 17.02 Billion by 2024
The artificial intelligence (AI) in medicine market was valued at USD 2.24 billion in 2018 and is projected to register a CAGR of 40.15% during the forecast period, 2019-2024 to reach a value of USD 17.02 billion by 2024. The rapidly increasing adoption of cloud computing techniques has facilitated the adoption of AI solutions for mining large amounts of data to identify mistakes in the present scenarios and offer alternative solutions in complex situations.
Read More
Copyright © 2000-2019 TradeMed.com. All rights reserved. | Terms And Conditions